Leslie N Weaver, LPC-S in Alabama, AL - Counselor

Leslie N Weaver, LPC-S is a Counselor - Professional based in Alabama, Alabama. Leslie N Weaver is licensed to practice in Alabama (license number 2991) and her current practice location is 656 Townsend Circle, Chickasaw, Alabama, Alabama. She can be reached at her office (for appointments etc.) via phone at (251) 751-7076.

NPI number for Leslie N Weaver is 1871191262 and her current mailing address is 656 Townsend Circle, Chickasaw, Alabama, Alabama. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1871191262.

Contact Information

	Leslie N Weaver, LPC-S
	656 Townsend Circle, Chickasaw, Alabama, AL 36611
	(251) 751-7076
	Not Available

Healthcare Provider's Profile

Full Name	Leslie N Weaver
Gender	Female
Speciality	Counselor - Professional
Location	656 Townsend Circle, Alabama, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1871191262
Provider Enumeration Date: 10/16/2020
Last Update Date: 10/16/2020

Medical Identifiers

Medical identifiers for Leslie N Weaver such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1871191262	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YP2500X	Counselor - Professional	2991 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leslie N Weaver is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Leslie N Weaver, LPC-S 656 Townsend Circle, Chickasaw, Alabama, AL 36611 Ph: (251) 751-7076	Leslie N Weaver, LPC-S 656 Townsend Circle, Chickasaw, Alabama, AL 36611 Ph: (251) 751-7076

News Archive

Researchers characterize new animal model that mimics aspects of AMD

Age-related macular degeneration affects roughly 200,000 individuals in the United States each year. In most, it comes on slowly, gradually blurring the central field of vision used for activities like reading and driving. While treatments exist to slow its progression, there is no cure.

Medicaid news: N.Y. Gov. proposes state 'takeover' of local costs; Kansas docs, hospitals endorse managed care plan

Gov. Andrew Cuomo's overall budget proposal would increase state spending by 2 percent, much of it involving 4-percent school aid and Medicaid spending hikes agreed to last year with legislative leaders. But the overall plan, including federal funding, is a fraction of 1 percent lower than the current budget, and eliminates a $2 billion deficit.

Competitive Technologies to introduce Calmare pain therapy at medical conference

Competitive Technologies, Inc. announced today that it will hold a conference for the medical community on May 17, 2010, in Boston, Mass. at the Marriott Long Wharf Hotel from 9:00 a.m. to 3:30 p.m., to introduce CTT's Calmare® pain therapy to the medical community. Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, is the Italian inventor of the "Scrambler Therapy," the technology used in the Calmare medical device.

Antibody treatment could significantly improve lives following spinal cord injury: Researchers

The United States Department of Defense Spinal Cord Injury Research Program has announced a grant of more than a million dollars U.S. to support research at the Robarts Research Institute at The University of Western Ontario (Western). The spinal cord injury research team of Gregory Dekaban, Arthur Brown, Lynne Weaver and Paula Foster, in collaboration with Brian Kwon of the University of British Columbia and Kyle Petersen of the U.S. Naval Medical Research Center, is working on a new therapy designed to limit the damage caused by inflammation immediately following spinal cord injury.

Harnessing power of cancer gene could lead to first curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.

Leslie N Weaver, LPC-S - Counselor in Alabama, AL